![]() |
Open for inclusion |
A Phase II, single arm, multicenter trial to determine the efficacy and safety of CTL019 in adult patients with relapsed or refractory DLBCLCancer type: Lymphoma Phase: II Principal Investigator: Holte Harald Country: NO Keywords: Norway, Oslo, Adults, CTL019 and diffuse large B-cell lymphoma (DLBCL) Status: Open for inclusion Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02445248?term=CTL019C2201&rank=1 |